National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report
Saro H. Armenian(City of Hope), Minoo Battiwalla(Sarah Cannon), Nina Salooja(Imperial College London), Lee W. Jones(Memorial Sloan Kettering Cancer Center), Alicia Rovó(University Hospital of Bern), Wassim Chemaitilly(St. Jude Children's Research Hospital), Marcus Y. Chen(National Institutes of Health), Alan T. Remaley(National Institutes of Health), Michael A. Pulsipher(Primary Children's Hospital), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Eric J. Chow(University of Washington)
Cited by 103
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
|European Heart Journal|2021|889
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592